Mesna
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Mesna Product Information
Mesna is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Mesna. The product is supplied by Clearsynth under CAT No. CS-T-31881.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Mesna
CAS No.
19767-45-4
CAT No.
CS-T-31881
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C2H5NaO3S2
Molecular Weight
164.18
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Mesna is supplied with detailed characterization data compliant with regulatory guideline. Mesna can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Mesna.
Overview
"Mesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs."
Synonyms
Mesna
Application Notes
"Mesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.